A controlled trial of rasagiline in early Parkinson disease: The tempo study

Andrew Siderowf, Matthew Stern, Ira Shoulson, Karl Kieburtz, David Oakes, Denni Day, Aileen Shinaman, Sandra Plumb, Stanley Fahn, Karen Blindauer, Mark Lew, Howard Hurtig, Mary Lloyd, Robert Hauser, Lisa Gauger, Lawrence Golbe, Joanne Wojcieszek, Joann Belden, Andrew Feigin, Mary Lou KlimekBarbara Shannon, William Ondo, Christine Hunter, Vincent Calabrese, Paul Atchison, Cathy Allen, Frederick Marshall, Debra Berry, Irenita Gardiner, Janis Miyasaki, Luisa Del Rizzo, Tilak Mendis, Neila Mendis, Peggy Gray, Jean Hubble, Karen Betcher, Rajesh Pahwa, Eric Molho, Diane Brown, Lisa Shulman, Ali Rajput, Marianne Ewanishin, Mark Stacy, Kelli Williamson, John Bertoni, Carolyn Peterson, Paul Tuite, Brenda Ebbitt, Kathleen Shannon, Jean Jaglin, Caroline Tanner, Kenneth Marek, Karen Stavris, Michael J. Aminoff, Mariann DiMinno, Glenna Dowling, Un Jung Kang, Judy Richman, Kapil Sethi, Wayne Martin, Pamela King, Germaine McInnes, Charles Adler, Peter LeWitt, Maryan DeAngelis, Myrna Schear, Mark Forrest Gordon, Roberta Winnick, Robert Feldman, Cathi Ann Thomas, Kelly Conn, Alicia Brocht, Chris Chadwick, Jeannette Connolly, Susan Daigneault, Shirley Eberly, Janice Bausch, Lee Josephson, Rosemary Oliva, Steven Schwid, Anthony Lang, Christopher Cox, Carrie Irvine, John Nutt, William White, Sheila Oren, Ruth Levy, Eli Eyal, David Ladkani, Wayne Houck

Research output: Contribution to journalArticlepeer-review

506 Scopus citations

Fingerprint

Dive into the research topics of 'A controlled trial of rasagiline in early Parkinson disease: The tempo study'. Together they form a unique fingerprint.

Arts & Humanities

Medicine & Life Sciences